Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Neuman Linda L — Spyre Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Neuman Linda L

Neuman Linda L

Chief Medical Officer at Spyre Therapeutics, Inc. · on record since Jan 27, 2023

Insider trading activity of Neuman Linda L

Transactions on record: 2; since Jan 27, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 24, 2023

Figures computed from official regulatory filings — methodology.

Companies where Neuman Linda L has traded

Spyre Therapeutics, Inc.2 tx · Feb 24, 2023

Track record of Neuman Linda L

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Neuman Linda L

Co-insiders of Neuman Linda L

667, L.P.Spyre Therapeutics, Inc.
Albers Jeffrey W.Spyre Therapeutics, Inc.
Alspaugh JonathanSpyre Therapeutics, Inc.
Baker Bros. Advisors (GP) LLCSpyre Therapeutics, Inc.
BAKER BROS. ADVISORS LPSpyre Therapeutics, Inc.
Baker Brothers Life Sciences LPSpyre Therapeutics, Inc.
BAKER FELIXSpyre Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BAKER JULIANSpyre Therapeutics, Inc.

Brownstein SaraSpyre Therapeutics, Inc.

Bruhn Suzanne LouiseSpyre Therapeutics, Inc.

Burrows Scott LSpyre Therapeutics, Inc.

Cox Russell J.Spyre Therapeutics, Inc.

Fairmount Funds Management LLCSpyre Therapeutics, Inc.

Fairmount Healthcare Co-Invest L.P.Spyre Therapeutics, Inc.

Fairmount Healthcare Fund II L.P.Spyre Therapeutics, Inc.

Fairmount Healthcare Fund L.P.Spyre Therapeutics, Inc.

GEORGIOU GEORGESpyre Therapeutics, Inc.

Goldberg Jeff MarcSpyre Therapeutics, Inc.

Hanley Jr. Michael ConickSpyre Therapeutics, Inc.

Harwin Peter EvanSpyre Therapeutics, Inc.

Hebel HenrySpyre Therapeutics, Inc.

HENDERSON MICHAEL THOMASSpyre Therapeutics, Inc.

ISALY SAMUEL DSpyre Therapeutics, Inc.

Kastenmayer James PaulSpyre Therapeutics, Inc.

King-Jones HeidySpyre Therapeutics, Inc.

Kiselak TomasSpyre Therapeutics, Inc.

LAWLIS V BRYANSpyre Therapeutics, Inc.

LAWTON ALISON FRANCISSpyre Therapeutics, Inc.

LILLY ELI & COSpyre Therapeutics, Inc.

Lilly Ventures Fund I LLCSpyre Therapeutics, Inc.

Lowe David GeorgeSpyre Therapeutics, Inc.

Magovcevic IvanaSpyre Therapeutics, Inc.

Mahatme SandeshSpyre Therapeutics, Inc.

McKenna Mark C.Spyre Therapeutics, Inc.

Milligan SandraSpyre Therapeutics, Inc.

NOVARTIS AGSpyre Therapeutics, Inc.

Novartis Bioventures LtdSpyre Therapeutics, Inc.

ORBIMED ADVISORS LLCSpyre Therapeutics, Inc.

OrbiMed Capital GP V LLCSpyre Therapeutics, Inc.

Quinn AnthonySpyre Therapeutics, Inc.

Rao Madduri RavinSpyre Therapeutics, Inc.

Rojas-Caro SandraSpyre Therapeutics, Inc.

Rowlinson Scott WSpyre Therapeutics, Inc.

Schuchart AaronSpyre Therapeutics, Inc.

Shanafelt ArmenSpyre Therapeutics, Inc.

Sloan LeslieSpyre Therapeutics, Inc.

Sloan SheldonSpyre Therapeutics, Inc.

Smith Hunter CSpyre Therapeutics, Inc.

Souza MarcioSpyre Therapeutics, Inc.

Stelzer LaurieSpyre Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Spyre Therapeutics, Inc.	Feb 24, 2023	AwardD	550,000	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jan 27, 2023	AwardD	25,000	0.00 USD	$0	SEC